Study of EPN-701 for the Treatment of Calciphylaxis (NCT07583745)
Phase 2 Study of EPN-701 for the Treatment of Calciphylaxis
🩺 Plain-English Summary (8th-Grade Level)
Calciphylaxis is a rare but serious condition that leads to painful skin lesions. At present, there is no approved treatment for calciphylaxis. This research study is planned to examine the potential benefits of a new treatment (EPN-701) in patients with calciphylaxis. The present early clinical study will also evaluate the pharmacology of EPN-701 and whether it can be safely used in patients with calciphylaxis. Findings will inform the planning of a future definitive study to establish EPN-701 as an approved treatment for calciphylaxis.
Who can join: Review the eligibility criteria below.
Location: Renal Associates — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Renal Associates — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (978) 406-3408
Email: skrinsky1@mgb.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Calciphylaxis
- Anti-Interleukin-6 (IL6) in Calciphylaxis — Boston, Massachusetts
- Partners Calciphylaxis Biobank — Boston, Massachusetts
Explore by condition: All Calciphylaxis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.